F. Gordon

2.6k total citations · 1 hit paper
44 papers, 1.5k citations indexed

About

F. Gordon is a scholar working on Epidemiology, Hepatology and Inorganic Chemistry. According to data from OpenAlex, F. Gordon has authored 44 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 12 papers in Hepatology and 12 papers in Inorganic Chemistry. Recurrent topics in F. Gordon's work include Liver Disease Diagnosis and Treatment (12 papers), Organometallic Complex Synthesis and Catalysis (9 papers) and Liver Disease and Transplantation (8 papers). F. Gordon is often cited by papers focused on Liver Disease Diagnosis and Treatment (12 papers), Organometallic Complex Synthesis and Catalysis (9 papers) and Liver Disease and Transplantation (8 papers). F. Gordon collaborates with scholars based in United Kingdom, United States and Germany. F. Gordon's co-authors include Stephen Donoghue, Subrata Ghosh, Paul Rutgeerts, P Vyhnálek, Eran Goldin, H Malchow, J Rask-Madsen, Zdena Zádorová, A. Stone and Kushala Abeysekera and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Gastroenterology.

In The Last Decade

F. Gordon

43 papers receiving 1.4k citations

Hit Papers

Natalizumab for Active Crohn's Disease 2003 2026 2010 2018 2003 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Gordon United Kingdom 15 688 552 380 280 181 44 1.5k
Gary Chan United States 22 562 0.8× 870 1.6× 595 1.6× 42 0.1× 275 1.5× 58 2.4k
Akira Mori Japan 24 317 0.5× 110 0.2× 86 0.2× 639 2.3× 624 3.4× 116 1.9k
Anke Krüger Germany 12 310 0.5× 71 0.1× 317 0.8× 223 0.8× 27 0.1× 19 953
Azhar Ansari United Kingdom 20 355 0.5× 661 1.2× 117 0.3× 198 0.7× 145 0.8× 51 1.7k
Yasunobu Kanamori Japan 26 245 0.4× 185 0.3× 130 0.3× 26 0.1× 328 1.8× 72 2.5k
Daniel L. Kisner United States 13 113 0.2× 195 0.4× 173 0.5× 20 0.1× 116 0.6× 32 928
David Sherlock United Kingdom 25 360 0.5× 88 0.2× 107 0.3× 757 2.7× 732 4.0× 83 2.0k
Kristine Zanotti United States 28 194 0.3× 110 0.2× 156 0.4× 23 0.1× 434 2.4× 68 2.4k
Michael Doukas Netherlands 18 184 0.3× 92 0.2× 105 0.3× 174 0.6× 393 2.2× 66 1.1k
Thierry Dervieux United States 29 205 0.3× 328 0.6× 499 1.3× 102 0.4× 86 0.5× 82 2.9k

Countries citing papers authored by F. Gordon

Since Specialization
Citations

This map shows the geographic impact of F. Gordon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Gordon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Gordon more than expected).

Fields of papers citing papers by F. Gordon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Gordon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Gordon. The network helps show where F. Gordon may publish in the future.

Co-authorship network of co-authors of F. Gordon

This figure shows the co-authorship network connecting the top 25 collaborators of F. Gordon. A scholar is included among the top collaborators of F. Gordon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Gordon. F. Gordon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Archer, Ann, Jennifer Phillips, Zoë Ward, et al.. (2024). Proactive case finding of alcohol‐related liver disease in high‐risk populations: A systematic review. Liver International. 44(6). 1298–1308. 1 indexed citations
3.
Abeysekera, Kushala, James Orr, F. Gordon, et al.. (2022). Evaluating future risk of NAFLD in adolescents: a prediction and decision curve analysis. BMC Gastroenterology. 22(1). 323–323. 5 indexed citations
4.
Abeysekera, Kushala, James Orr, Paul Madley‐Dowd, et al.. (2021). Association of maternal pre-pregnancy BMI and breastfeeding with NAFLD in young adults: a parental negative control study. The Lancet Regional Health - Europe. 10. 100206–100206. 17 indexed citations
5.
Ankcorn, Michael, Bengü Said, Dilys Morgan, et al.. (2020). Persistent Hepatitis E virus infection across England and Wales 2009‐2017: Demography, virology and outcomes. Journal of Viral Hepatitis. 28(2). 420–430. 14 indexed citations
6.
Roberts, Kirsty, John Macleod, Chris Metcalfe, et al.. (2020). Cost effectiveness of an intervention to increase uptake of hepatitis C virus testing and treatment (HepCATT): cluster randomised controlled trial in primary care. BMJ. 368. m322–m322. 16 indexed citations
7.
Johnson, Philip J., Sarah Berhane, Alex J Walker, et al.. (2020). Impact of direct‐acting antiviral agents on liver function in patients with chronic hepatitis C virus infection. Journal of Viral Hepatitis. 28(1). 168–176. 7 indexed citations
8.
Abeysekera, Kushala, Gwen Fernandes, Gemma Hammerton, et al.. (2020). Prevalence of steatosis and fibrosis in young adults in the UK: a population-based study. ˜The œLancet. Gastroenterology & hepatology. 5(3). 295–305. 126 indexed citations
9.
Wong, Newton A C S, et al.. (2019). Cell block processing is optimal for assessing endoscopic ultrasound fine needle aspiration specimens of pancreatic mucinous cysts. Journal of Clinical Pathology. 73(2). 102–106. 4 indexed citations
10.
Roberts, Kirsty, John Macleod, Chris Metcalfe, et al.. (2016). Hepatitis C – Assessment to Treatment Trial (HepCATT) in primary care: study protocol for a cluster randomised controlled trial. Trials. 17(1). 366–366. 12 indexed citations
11.
Khalid, Tanzeela, Ben de Lacy Costello, Richard J. Ewen, et al.. (2012). PWE-287 Breath volatile analysis for the recognition of harmful drinking, cirrhosis and hepatic encephalopathy. Gut. 61(Suppl 2). A414.2–A415. 2 indexed citations
12.
Parker, Richard, et al.. (2011). In vitro steroid resistance correlates with outcome in severe alcoholic hepatitis. Hepatology. 53(4). 1316–1322. 23 indexed citations
13.
Andersson, Monique, et al.. (2008). Of pigs and pregnancy. The Lancet. 372(9644). 1192–1192. 23 indexed citations
14.
Parker, Richard & F. Gordon. (2008). A Different Cause of Erythema Ab Igne in Chronic Pancreatitis. Pancreatology. 8(4-5). 532–532. 1 indexed citations
15.
Ghosh, Subrata, Eran Goldin, F. Gordon, et al.. (2003). Natalizumab for Active Crohn's Disease. New England Journal of Medicine. 348(1). 24–32. 615 indexed citations breakdown →
16.
Gordon, F., Clement Lai, Mark I. Hamilton, et al.. (2001). A randomized placebo-controlled trial of a humanized monoclonal antibody to α4 integrin in active crohn's disease. Gastroenterology. 121(2). 268–274. 243 indexed citations
17.
López, Jesús Talavera, et al.. (1997). Effect of chemotherapy on thyroid hormone concentration in patients with malignant hematologic diseases.. PubMed. 28(2). 215–7. 4 indexed citations
18.
Gordon, F., et al.. (1992). Reactions of the tungsten alkylidyne complexes [W(CCCR)(CO)2(η-C5H5)] (R C6H4Me-4 OR But). Polyhedron. 11(13). 1607–1613. 3 indexed citations
19.
Beck, Wolfgang, et al.. (1989). Metallorganische Lewissäuren. Journal of Organometallic Chemistry. 368(1). 77–81. 4 indexed citations
20.
Devore, David D., et al.. (1988). Docosahedral carbaboranetungsten-alkylidyne complexes: synthesis of compounds with heteronuclear metal-metal bonds. Journal of Organometallic Chemistry. 358(1-3). C6–C10. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026